BIB

ProShares$82.75+0.48 (+0.58%)
AUM $71.6MER 1.19%NAV $82.35Holdings 274

Price Chart

Key Statistics

Previous Close

$82.27

Day Range

$82.75$83.89

52-Week Range

$45.06$89.34

Avg Volume

5.2K

Dividend Yield

0.75%

Expense Ratio

1.19%

AUM

$71.6M

Shares Outstanding

870.0K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare64.66%
Cash & Others28.17%
Financial Services7.17%

Country Allocation

CountryWeight %
United States62.44%
Other29.36%
United Kingdom1.72%
Netherlands1.61%
Ireland1.22%
France0.89%
Denmark0.77%
Switzerland0.75%
Germany0.52%
Canada0.44%
Luxembourg0.06%
Singapore0.06%
Spain0.05%
Australia0.04%
China0.03%
Belgium0.02%
Israel0.02%
Taiwan0.01%

Fund Information

Issuer
ProShares
Category
Healthcare
Inception Date
Apr 7, 2010
Exchange
NASDAQ
Description
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$39.34B
VHTVanguard Health Care ETF$18.50B
COWZPacer US Cash Cows 100 ETF$18.08B
RWLInvesco S&P 500 Revenue ETF$9.15B
XBIState Street SPDR S&P Biotech ETF$8.11B

The ProShares - Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund issued by ProShares that launched on Apr 7, 2010. It currently manages $71.6M in assets under management. The fund charges an expense ratio of 1.19%. The fund holds 274 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 59.7% of the fund

RankSymbolNameWeight %SharesMarket Value
1Net Other Assets (Liabilities)29.00%20,772,773$20.8M
2IQMMPROSHARES GENIUS MNY MKT ETF6.99%50,000$5.0M
3AMGNAMGEN INC4.84%9,803$3.5M
4VRTXVERTEX PHARMACEUTICALS INC4.76%7,657$3.4M
5GILDGILEAD SCIENCES INC4.49%25,542$3.2M
6REGNREGENERON PHARMACEUTICALS3.28%3,840$2.3M
7ALNYALNYLAM PHARMACEUTICALS INC1.98%4,904$1.4M
8RVMDREVOLUTION MEDICINES INC1.53%7,326$1.1M
9BIIBBIOGEN INC1.51%5,425$1.1M
10ARGXARGENX SE - ADR1.32%1,050$944K
11ILMNILLUMINA INC1.31%5,653$940K
12UTHRUNITED THERAPEUTICS CORP1.23%1,620$884K
13RPRXROYALTY PHARMA PLC- CL A1.22%15,837$876K
14INCYINCYTE CORP1.11%7,359$794K
15ROIVROIVANT SCIENCES LTD1.10%26,460$787K
Page 1 of 6

Detailed Returns

PeriodReturnETF
1D
+0.58%
1W
+5.07%
1M
+2.97%
3M
+3.05%
6M
+4.20%
YTD
+6.16%
1Y
+75.56%
3Y
+46.00%
5Y
-11.05%

Moving Averages

20-Day MA

$80.96

Above 20-Day MA
50-Day MA

$82.71

Above 50-Day MA
200-Day MA

$75.54

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$89.34

Current Price

$82.75

52-Week Low

$45.06

$45.06$89.34

Current Yield

0.75%

Annual Dividend

$0.6167

Frequency

4x/year

Last Ex-Date

Dec 24, 2025

Dividend History

Ex-DateAmountPay Date
Dec 24, 2025$0.1346Dec 31, 2025
Sep 24, 2025$0.1805Sep 30, 2025
Jun 25, 2025$0.1706Jul 1, 2025
Mar 26, 2025$0.1309Apr 1, 2025
Dec 23, 2024$0.3964Dec 31, 2024
Sep 25, 2024$0.1528Oct 2, 2024
Jun 26, 2024$0.2648Jul 3, 2024
Mar 20, 2024$0.0403Mar 27, 2024
Dec 20, 2023$0.0384Dec 28, 2023
Dec 22, 2022$0.0199Dec 30, 2022
Sep 21, 2010$0.0878Sep 28, 2010

Dividend Payments Over Time

Category Comparison

MetricBIBHealthcare(176 ETFs)Biotech(41 ETFs)
Fund Info
Expense Ratio1.19%0.61%0.83%
AUM$71.6M$910.0M$1.52B
Dividend Yield0.75%3.35%1.97%
Avg Volume5.2K275.1K871.8K
Holdings2749965
Performance
1-Month Return-3.89%+1.77%+4.73%
6-Month Return+4.05%+3.26%+5.11%
YTD Return+3.60%+3.61%+6.25%
1-Year Return+75.22%+24.59%+37.13%

Compare with Another ETF

Search for an ETF to compare with BIB:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.